165 related articles for article (PubMed ID: 31374521)
1. Synthesis, physicochemical and biological evaluation of tacrine derivative labeled with technetium-99m and gallium-68 as a prospective diagnostic tool for early diagnosis of Alzheimer's disease.
Gniazdowska E; Koźmiński P; Halik P; Bajda M; Czarnecka K; Mikiciuk-Olasik E; Masłowska K; Rogulski Z; Cheda Ł; Kilian K; Szymański P
Bioorg Chem; 2019 Oct; 91():103136. PubMed ID: 31374521
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, physicochemical and biological studies of technetium-99m labeled tacrine derivative as a diagnostic tool for evaluation of cholinesterase level.
Gniazdowska E; Koźmiński P; Wasek M; Bajda M; Sikora J; Mikiciuk-Olasik E; Szymański P
Bioorg Med Chem; 2017 Feb; 25(3):912-920. PubMed ID: 27998671
[TBL] [Abstract][Full Text] [Related]
3. New Imaging Modality of COVID-19 Pneumonia Developed on the Basis of Alzheimer's Disease Research.
Koźmiński P; Niedziałek D; Wieczorek G; Halik PK; Czarnecka K; Rogut A; Cheda Ł; Rogulski Z; Szymański P; Gniazdowska E
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955536
[TBL] [Abstract][Full Text] [Related]
4. New tacrine-hydrazinonicotinamide hybrids as acetylcholinesterase inhibitors of potential interest for the early diagnostics of Alzheimer's disease.
Szymański P; Zurek E; Mikiciuk-Olasik E
Pharmazie; 2006 Apr; 61(4):269-73. PubMed ID: 16649535
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease.
Hamulakova S; Janovec L; Hrabinova M; Kristian P; Kuca K; Banasova M; Imrich J
Eur J Med Chem; 2012 Sep; 55():23-31. PubMed ID: 22818849
[TBL] [Abstract][Full Text] [Related]
6. Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study.
Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Edraki N; Sharifzadeh M; Khanavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():303-316. PubMed ID: 30396115
[TBL] [Abstract][Full Text] [Related]
7. Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease.
Chen Y; Sun J; Peng S; Liao H; Zhang Y; Lehmann J
Arch Pharm (Weinheim); 2013 Dec; 346(12):865-71. PubMed ID: 24203864
[TBL] [Abstract][Full Text] [Related]
8. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
[TBL] [Abstract][Full Text] [Related]
9. Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
El-Malah A; Gedawy EM; Kassab AE; Salam RM
Arch Pharm (Weinheim); 2014 Feb; 347(2):96-103. PubMed ID: 24343873
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
Pourabdi L; Khoobi M; Nadri H; Moradi A; Moghadam FH; Emami S; Mojtahedi MM; Haririan I; Forootanfar H; Ameri A; Foroumadi A; Shafiee A
Eur J Med Chem; 2016 Nov; 123():298-308. PubMed ID: 27484515
[TBL] [Abstract][Full Text] [Related]
11. Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments.
Bautista-Aguilera ÓM; Ismaili L; Iriepa I; Diez-Iriepa D; Chabchoub F; Marco-Contelles J; Pérez M
Chem Rec; 2021 Jan; 21(1):162-174. PubMed ID: 33169934
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Cholinesterase Inhibitory Activity of N-Phosphorylated/ N-Tiophosphorylated Tacrine.
Przybyłowska M; Inkielewicz-Stepniak I; Kowalski S; Dzierzbicka K; Demkowicz S; Daśko M
Med Chem; 2020; 16(7):947-957. PubMed ID: 31309898
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Potential of Multifunctional Tacrine Analogues.
Przybyłowska M; Kowalski S; Dzierzbicka K; Inkielewicz-Stepniak I
Curr Neuropharmacol; 2019; 17(5):472-490. PubMed ID: 29651948
[TBL] [Abstract][Full Text] [Related]
14. New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.
Fernández-Bachiller MI; Pérez C; Monjas L; Rademann J; Rodríguez-Franco MI
J Med Chem; 2012 Feb; 55(3):1303-17. PubMed ID: 22243648
[TBL] [Abstract][Full Text] [Related]
15. NO-donating tacrine derivatives as potential butyrylcholinesterase inhibitors with vasorelaxation activity.
Chen Y; Sun J; Huang Z; Liao H; Peng S; Lehmann J; Zhang Y
Bioorg Med Chem Lett; 2013 Jun; 23(11):3162-5. PubMed ID: 23639542
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of new tacrine-like analogues.
Marco JL; de los Ríos C; Carreiras MC; Baños JE; Badía A; Vivas NM
Bioorg Med Chem; 2001 Mar; 9(3):727-32. PubMed ID: 11310608
[TBL] [Abstract][Full Text] [Related]
17. Thieno[2,3-b]pyridine amines: Synthesis and evaluation of tacrine analogs against biological activities related to Alzheimer's disease.
Saeedi M; Safavi M; Allahabadi E; Rastegari A; Hariri R; Jafari S; Bukhari SNA; Mirfazli SS; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
Arch Pharm (Weinheim); 2020 Oct; 353(10):e2000101. PubMed ID: 32657467
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates.
Fang L; Appenroth D; Decker M; Kiehntopf M; Roegler C; Deufel T; Fleck C; Peng S; Zhang Y; Lehmann J
J Med Chem; 2008 Feb; 51(4):713-6. PubMed ID: 18232655
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and molecular-modeling study of aminothienopyridine analogues of tacrine for Alzheimer's disease.
Badran MM; Abdel Hakeem M; Abuel-Maaty SM; El-Malah A; Abdel Salam RM
Arch Pharm (Weinheim); 2010 Oct; 343(10):590-601. PubMed ID: 20925094
[TBL] [Abstract][Full Text] [Related]
20. Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity.
Mao F; Chen J; Zhou Q; Luo Z; Huang L; Li X
Bioorg Med Chem Lett; 2013 Dec; 23(24):6737-42. PubMed ID: 24220172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
